Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank87
3Y CAGR+1.4%
5Y CAGR+10.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.4%/yr
vs +10.2%/yr prior
5Y CAGR
+10.8%/yr
Recent deceleration
Acceleration
-8.8pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.61M | -11.4% |
| 2024 | $41.31M | -20.6% |
| 2023 | $52.00M | +48.0% |
| 2022 | $35.13M | +37.3% |
| 2021 | $25.58M | +16.6% |
| 2020 | $21.95M | +1.4% |
| 2019 | $21.65M | -9.1% |
| 2018 | $23.83M | -11.5% |
| 2017 | $26.91M | +0.2% |
| 2016 | $26.85M | - |